Exact knowledge of the crystal structure of drugs and lead compounds plays a significant role in the fields of crystal engineering, docking, computational modeling (drug−receptor interactions), and rational design of potent drugs in pharmaceutical chemistry. The succinic acid cocrystal of the systemic antifungal drug, itraconazole, reported by Remenar et al. (J. Am. Chem. Soc. 2003, 125, 8456−8457) (CSD: IKEQEU), represents one of the classical examples displaying a molecular fitting mechanism in the solid state. In this work, we disclose the X-ray single-crystal structure of the cis-itraconazole−succinic acid (2:1) cocrystal and found that it differs slightly from the previously reported structure by the location of the elements (C, H, and N) in the 1,2,4-triazol-5-one ring. By making use of the new solid-state structure, we have also applied an enhanced disorder model, which, in turn, uncovered the intriguing halogen bond (XB) interactions (0.86 × van der Waals distance of C−Cl•••N), which were previously unnoticed. Furthermore, the crystal structure of cis-itraconazole reported by Peeters et al. (Acta Crystallogr. 1996, C52, 2225−2229 (CSD: TEHZIP) is also revisited. For the structure of neat cis-itraconazole, new low-temperature as well as a revised ambient temperature (0 °C) X-ray single crystal structures with new disorder models are described. More importantly, a weak halogen bonding interaction (0.9 × van der Waals distance of C− Cl•••O) has now been perceived in this structure. The XB contacts remained without consideration in the original report primarily due to the lack of its recognition, at that time. In addition to these new findings, solid-state NMR and the thermoanalytical properties were examined by thermogravimetric analysis and differential scanning calorimetry.